Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical Trial Not Allowed)
Ceiling: $3,500,000
Applications Due:
Closed
Federal
HHS-NIH11 (National Institutes of Health)
Description
The purpose of this notice of funding opportunity (NOFO) is to support the evaluation of early-stage diagnostics and novel diagnostic strategies for Tuberculosis (TB) in the context of existing clinical algorithms in TB endemic countries. Evaluation studies should: 1) perform proof-of principle studies of novel diagnostic tests and strategies for TB, including among people living with HIV (PLWH) and 2) provide feedback to diagnostic developers and policy makers on the performance of the technologies and most effective strategies for use of the diagnostic technologies in an endemic setting.
Eligibility
States
All
Regions
All
Eligible Entities
State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal organizations, Public housing authorities, Nonprofits
Funding
Program Funding
Award Ceiling
$3,500,000
Award Floor
Award Count
Timing
Posted Date
March 28, 2024
App Status
No Longer Accepting Applications
Funder
Funding Source
Source Type
Federal
Contact Name
NIH Grants Information
Contact Email
Contact Phone
--